000 01426 a2200373 4500
005 20250515070202.0
264 0 _c20070814
008 200708s 0 0 eng d
022 _a1558-2027
024 7 _a10.2459/JCM.0b013e3280111345
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGoldhammer, Ehud
245 0 0 _aThe early anti-oxidant effect of carvedilol predicts the clinical course in congestive heart failure patients.
_h[electronic resource]
260 _bJournal of cardiovascular medicine (Hagerstown, Md.)
_cJun 2007
300 _a453-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdrenergic alpha-Antagonists
_xtherapeutic use
650 0 4 _aAdrenergic beta-Antagonists
_xtherapeutic use
650 0 4 _aCarbazoles
_xtherapeutic use
650 0 4 _aCarvedilol
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMyocardial Infarction
_xdrug therapy
650 0 4 _aPropanolamines
_xtherapeutic use
650 0 4 _aReactive Oxygen Species
_xmetabolism
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
700 1 _aMaor, Irit
700 1 _aShnitzer, Sergei
700 1 _aLanir, Amos
700 1 _aAbinader, Edward G
773 0 _tJournal of cardiovascular medicine (Hagerstown, Md.)
_gvol. 8
_gno. 6
_gp. 453-6
856 4 0 _uhttps://doi.org/10.2459/JCM.0b013e3280111345
_zAvailable from publisher's website
999 _c17047480
_d17047480